Lv12
16 积分 2024-05-08 加入
什么时候才能不上班
Medical Therapy with Antimuscarinics and ß3-Agonists
3小时前
待确认
Combination and Novel Pharmacologic Agents for OAB
1天前
已完结
Screening and treatment of thalassemia
12天前
已完结
Tumor mutation burden-assisted risk stratification for papillary thyroid cancer
12天前
已完结
Structures and mechanism of human mitochondrial pyruvate carrier
13天前
已完结
Overactive bladder in women
13天前
已完结
Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)
16天前
已完结
CO-STAR: Surgical conversion feasibility trial of sintilimab (PD-1 inhibitor) combined with Nab-PTX, S-1 and apatinib for the first-line treatment of stage IV gastric cancer (GC)
17天前
已关闭
Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability–High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study
17天前
已完结
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer
17天前
已完结
皖公网安备34019202002308
